Evidence map›Paper›PMID 35360044›Full record

ArticleOsteoarthritis and cartilage open2021

DNA methylation and noncoding RNA in OA: Recent findings and methodological advances.

Vladislav Izda, Jake Martin, Cassandra Sturdy, Matlock A Jeffries

Open access · goldAbstract read
In one paragraph

Article in Osteoarthritis and cartilage open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vladislav IzdaOklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, USA.
Jake MartinOklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, USA.
Cassandra SturdyOklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, USA.
Matlock A JeffriesOklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, USA.
Oklahoma Medical Research Foundation · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI William Edmund Sonntag · 2019 to 2026
$17.8M
Molecular Mechanisms and Genetics of AutoimmunityP20GM103456 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2013
$4.8M
Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression.R01AR076440 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BHUTANI, NIDHI, JEFFRIES, MATLOCK · 2020 to 2025
$3.6M
An integrative study of circulating leukocyte composition, epigenetic patterns, and functional consequences in knee osteoarthritis.K08AR070891 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JEFFRIES, MATLOCK · 2017 to 2021
$862k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR61AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2020 to 2021
$861k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR33AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2022 to 2022
$437k
NIAMS NIH HHS K08 AR070891NIAMS NIH HHS R01 AR076440NIAMS NIH HHS R33 AR078075NIAMS NIH HHS R61 AR078075NIGMS NIH HHS P20 GM103456NIGMS NIH HHS P20 GM125528
6 · The paper itself

Abstract

Introduction: Osteoarthritis (OA) is a chronic musculoskeletal disease characterized by progressive loss of joint function. Historically, it has been characterized as a disease caused by mechanical trauma, so-called 'wear and tear'. Over the past two decades, it has come to be understood as a complex systemic disorder involving gene-environmental interactions. Epigenetic changes have been increasingly implicated. Recent improvements in microarray and next-generation sequencing (NGS) technologies have allowed for ever more complex evaluations of epigenetic aberrations associated with the development and progression of OA. Methods: A systematic review was conducted in the Pubmed database. We curated studies that presented the results of DNA methylation and noncoding RNA research in human OA and OA animal models since 1985. Results: Herein, we discuss recent findings and methodological advancements in OA epigenetics, including a discussion of DNA methylation, including microarray and NGS studies, and noncoding RNAs. Beyond cartilage, we also highlight studies in subchondral bone and peripheral blood mononuclear cells, which highlight widespread and potentially clinically important alterations in epigenetic patterns seen in OA patients. Finally, we discuss epigenetic editing approaches in the context of OA. Conclusions: Although a substantial body of literature has already been published in OA, much is still unknown. Future OA epigenetics studies will no doubt continue to broaden our understanding of underlying pathophysiology and perhaps offer novel diagnostics and/or treatments for human OA.

Indexed as

DNA methylationEpigeneticsLiterature reviewNoncoding RNAOsteoarthritis

Identifiers

PMID35360044
PMCPMC8966627
OpenAlexW3195773891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.